UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 151

Sortiert nach

NADPH Oxidases, Reactive Oxygen Species, and the Kidney: Friend and Foe

Journal of the American Society of Nephrology, 2013-10, Vol.24 (10), p.1512-1518

2013

Volltextzugriff (PDF)

NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities

Diabetes care, 2008-02, Vol.31 (2), p.S170-S180

2008

Volltextzugriff (PDF)

Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in Hypertension: What Is the Clinical Significance?

Hypertension (Dallas, Tex. 1979), 2004-09, Vol.44 (3), p.248-252

Touyz, Rhian M

2004

Volltextzugriff (PDF)

Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy

Journal of the American Society of Nephrology, 2014-06, Vol.25 (6), p.1237-1254

2014

Volltextzugriff (PDF)

Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts

Arteriosclerosis, thrombosis, and vascular biology, 2011-08, Vol.31 (8), p.1898

2011

Volltextzugriff (PDF)

NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis

Circulation (New York, N.Y.), 2013-05, Vol.127 (18), p.1888-1902

2013

Volltextzugriff (PDF)

Vascular Smooth Muscle Cell Differentiation to an Osteogenic Phenotype Involves TRPM7 Modulation by Magnesium

Hypertension (Dallas, Tex. 1979), 2010-09, Vol.56 (3), p.453-462

2010

Volltextzugriff (PDF)

Urinary Podocyte Microparticles Identify Prealbuminuric Diabetic Glomerular Injury

Journal of the American Society of Nephrology, 2014-07, Vol.25 (7), p.1401-1407

2014

Volltextzugriff (PDF)

Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5

Clinical science (1979), 2011-02, Vol.120 (4), p.131

2011

Volltextzugriff (PDF)

A new look at the renin–angiotensin system—Focusing on the vascular system

Peptides (New York, N.Y. : 1980), 2011-10, Vol.32 (10), p.2141-2150

2011

Volltextzugriff (PDF)

Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart

Circulation research, 2008-11, Vol.103 (11), p.1319-1326

2008

Volltextzugriff (PDF)

Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction

Hypertension (Dallas, Tex. 1979), 2012-05, Vol.59 (5), p.1069-1078

2012

Volltextzugriff (PDF)

Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells

Hypertension (Dallas, Tex. 1979), 2007-12, Vol.50 (6), p.1093-1098

2007

Volltextzugriff (PDF)

Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients

Hypertension (Dallas, Tex. 1979), 2008-02, Vol.51 (2, Part 2), p.432-439

2008

Volltextzugriff (PDF)

Nephropathy and Elevated BP in Mice with Podocyte-Specific NADPH Oxidase 5 Expression

Journal of the American Society of Nephrology, 2014-04, Vol.25 (4), p.784-797

2014

Volltextzugriff (PDF)

Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 5 (Nox5) Regulation by Angiotensin II and Endothelin-1 Is Mediated via Calcium/Calmodulin-Dependent, Rac-1–Independent Pathways in Human Endothelial Cells

Circulation research, 2010-04, Vol.106 (8), p.1363-1373

2010

Volltextzugriff (PDF)

Dysregulation of Vascular TRPM7 and Annexin-1 Is Associated With Endothelial Dysfunction in Inherited Hypomagnesemia

Hypertension (Dallas, Tex. 1979), 2009-02, Vol.53 (2, Part 2 Suppl), p.423-429

2009

Volltextzugriff (PDF)

Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction

Circulation (New York, N.Y.), 2004-10, Vol.110 (15), p.2233-2240

2004

Volltextzugriff (PDF)

Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress

Hypertension (Dallas, Tex. 1979), 2002-10, Vol.40 (4), p.504-510

2002

Volltextzugriff (PDF)

Testosterone Induces Vascular Smooth Muscle Cell Migration by NADPH Oxidase and c-Src–Dependent Pathways

Hypertension (Dallas, Tex. 1979), 2012-06, Vol.59 (6), p.1263-1271

2012

Volltextzugriff (PDF)

Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury

Arteriosclerosis, thrombosis, and vascular biology, 2005-10, Vol.25 (10), p.2106

2005

Volltextzugriff (PDF)

Adipocyte-Derived Factors Regulate Vascular Smooth Muscle Cells Through Mineralocorticoid and Glucocorticoid Receptors

Hypertension (Dallas, Tex. 1979), 2011-09, Vol.58 (3), p.479-488

2011

Volltextzugriff (PDF)

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

Circulation (New York, N.Y.), 2000-04, Vol.101 (14), p.1653-1659

2000

Volltextzugriff (PDF)

Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice

Journal of hypertension, 2004-03, Vol.22 (3), p.535-542

2004

Volltextzugriff (PDF)

Exercise Reverses Metabolic Syndrome in High-Fat Diet―Induced Obese Rats

Medicine and science in sports and exercise, 2011-03, Vol.43 (3), p.398-407

2011

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(135)

Publikationsform

Artikel
(150)
Tagungsberichte
(1)

Sprache

Englisch
(151)
Japanisch
(46)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

NADPH Oxidases, Reactive Oxygen Species, and the Kidney: Friend and Foe

NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities

Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in Hypertension: What Is the Clinical Significance?

Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy

Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts

NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis

Vascular Smooth Muscle Cell Differentiation to an Osteogenic Phenotype Involves TRPM7 Modulation by Magnesium

Urinary Podocyte Microparticles Identify Prealbuminuric Diabetic Glomerular Injury

Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5

A new look at the renin–angiotensin system—Focusing on the vascular system

Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart

Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction

Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells

Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients

Nephropathy and Elevated BP in Mice with Podocyte-Specific NADPH Oxidase 5 Expression

Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 5 (Nox5) Regulation by Angiotensin II and Endothelin-1 Is Mediated via Calcium/Calmodulin-Dependent, Rac-1–Independent Pathways in Human Endothelial Cells

Dysregulation of Vascular TRPM7 and Annexin-1 Is Associated With Endothelial Dysfunction in Inherited Hypomagnesemia

Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction

Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress

Testosterone Induces Vascular Smooth Muscle Cell Migration by NADPH Oxidase and c-Src–Dependent Pathways

Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury

Adipocyte-Derived Factors Regulate Vascular Smooth Muscle Cells Through Mineralocorticoid and Glucocorticoid Receptors

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice

Exercise Reverses Metabolic Syndrome in High-Fat Diet―Induced Obese Rats

Aktive Filter

Suchergebnisse filtern